Abwiz Bio was founded in September 2012 by two scientists in San Diego to address the quality issues of antibodies currently used in research.Â
Along with its strong selection strategies, Abwiz Bio's unique cloning method "WizAmpâ„¢" (US 9,890,414) enables them to obtain a wide range of antibodies that could have been missed by hybridoma technology or other phage display methods. Their fully-functional rabbit monoclonal antibodies developed from the "RabWizâ„¢" technology have more diverse recognition of antigen epitopes with higher-specificity and higher-affinity than our competitors, facilitating reliable target detection. Abwiz Bio has also developed a mouse recombinant antibody production and development platform using their phage technology.
Abwiz Bio provides the highest quality monoclonal antibodies to the research reagent, clinical diagnostics, and therapeutics industries. They develop monoclonal antibodies and license and/or OEM our products to their customers, as well as help customers, develop monoclonal antibodies as a contract research organization. Check our website today to see how Abwiz Bio‘s recombinant antibody production and development platform can help you.
Â
Toshi Maruyama
MD, PhDÂ
Founder and COO/CSOÂ
Toshi Maruyama is the Chief Operating Officer (COO) and Chief Scientific Officer (CSO).Â
As COO/CSO, he is responsible for research, development, and manufacture of products.
Prior to founding Abwiz Bio, he acquired his skills in phage display in the lab of Dennis Burton at The Scripps Research Institute, La Jolla, CA and has held several senior scientist and management roles at Alexion Antibody Technologies, Calmune, and Nitto Denko Technical, USA.Â
He has close to 20 years of antibody development experience in academia and pharma. Toshi obtained his MD and PhD degree at Tokyo Medical and Dental University.
CJ OkumuraÂ
PhD, MBA
Founder and CEO
CJ Okumura is the Chief Executive Officer (CEO), and is responsible for strategy and directing of the company.Â
Prior to founding Abwiz Bio, CJ held a senior business development leadership position in BioLegend. He was a post doctoral fellow at Nolan laboratory in Stanford University and Dr Hirohisa Saito laboratory in Riken Research Center for Allergy and Immunology. Expertise in Immunology, molecular biology and business development.Â
CJ holds MBA at UCSD, RADY School of management, DDS and PhD at Tokyo Dental College.
Every Abwiz Bio phosphorylation-specific antibody is a rabbit monoclonal recombinant antibody. Recombinant mAbs are fully characterized by sequencing and exhibit significantly lower batch-to-batch variability compared to hybridoma or polyclonal antibodies. Our phosphorylation-specific research reagents are rigorously validated for flow cytometry and/or Western blot use.Â
Abwiz Bio Technologies
Founded in 2012, Abwiz Bio provides high-quality recombinant rabbit monoclonal antibodies for life science research needs.
By using phage-based development, Abwiz Bio produce sequenced, recombinant antibodies – reducing lot-to-lot variability and meeting stringent standards.
Phospho-Western: Western blot screening using Abwiz Bio’s phosphorylation-specific IgG antibodies
Loading ....